MG217 Multi-Symptom Treatment Cream & Skin Protectant 2% Recall: Sterility Concern
MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O.…
What is the FDA recall status?
The FDA record lists this recall as ongoing. FDA enforcement data is not a live recall-lifecycle tracker. Follow the official instructions and check the agency notice or firm for current guidance.
Why was MG217 Multi-Symptom Treatment Cream recalled?
Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.
What should I do if I have this product?
Follow the firm and FDA instructions for the affected product. Contact the recalling firm for current guidance.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare your product with the product description and available lot, UPC or model codes below from the official FDA record to check whether it is covered by this recall. If an identifier is missing or unclear, check the complete official notice or contact the firm; an incomplete match here does not establish that your product is unaffected.
Full product description
MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.
Which lot codes, UPCs or models are affected?
Lot #: 1024088, Exp 11/30/2026
- Agency record number
- D-0553-2026
- Product
- MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O.…
- Recalling firm
- Wisconsin Pharmacal Company
- Quantity
- 690 tubes
- Distribution
- USA Nationwide and Bahamas
- Recall started
- April 24, 2026
- Report date
- May 27, 2026
- Classification
- Class I
- Status
- Ongoing
- Agency
- FDA (drug)